Unresectable Locally Advanced Pancreatic Carcinoma
3 clinical trials · Condition
◉ Watch Unresectable Locally Advanced Pancreatic Carcinoma
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC) (NCT07555587) | NRT MedTech Australia Pty Ltd | 2026-09-01 |
| A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel. (NCT03076216) | OncoSil Medical Limited | 2017-08-01 |
| A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane (NCT03003078) | OncoSil Medical Limited | 2017-03-27 |
Track Unresectable Locally Advanced Pancreatic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.